Overview
Services

FRONTEO,Inc.

FRONTEO is a Japanese AI technology company that develops and provides enterprise AI solutions powered by its proprietary natural language processing AI engine 'KIBIT,' which uses mathematical approaches to extract insights from unstructured text data. The company operates across two segments: AIソリューション (AI Solutions), which covers Life Science AI (AI drug discovery support via 'Drug Discovery AI Factory,' AI medical devices for cognitive assessment), Business Intelligence (compliance/audit monitoring, knowledge transfer), and Economic Security (supply chain risk analysis, shareholder network analysis); and Legal Tech AI, which provides e-discovery support and digital forensic investigation services primarily in Japan and Korea. KIBIT is adopted by 100% of Japan's mega-bank groups and 80% of the five major securities firms, reflecting strong penetration among large Japanese enterprises.

Market Cap
¥27.4B
US$175M
EV
¥27.6B
US$176M
Stock¥700▼-0.43%
US$1 = ¥156.80 (2026-10-23)
LTM EV/EBITDA
26.3
x
LTM EV/EBIT
42.6
x
LTM PER
45.2
x
LTM PBR
7.7
x
Stock vs TOPIX (1Y, base=100)vs TOPIX ▼-47.5%pt
100
Oct 24, 25 – Oct 23, 26StockTOPIX
MC → EV Bridge
27.4BUS$175MMarket Cap3.90BUS$24.8M+ Debt1.45BUS$9.23M− Cash2.30BUS$14.6M− Inv. Sec.27.6BUS$176MEV
AI Briefing
Generating insights…
Performance & Balance
Revenue 5Y (¥B)
10.9US$69.7M'22/37.22US$46.0M'23/37.38US$47.0M'24/36.10US$38.9M'25/37.64US$48.7M'26/3
EBITDA 5Y (¥B)
2.58US$16.5M'22/3-0.60-US$3.81M'23/30.50US$3.16M'24/30.87US$5.56M'25/31.11US$7.11M'26/3
Net Income 5Y (¥B)
1.31US$8.34M'22/3-1.70-US$10.8M'23/3-2.84-US$18.1M'24/30.56US$3.54M'25/30.54US$3.47M'26/3
Capital Structure
48%
52%
EquityD/E 1.09xDebt
Liquidity vs Debt 5Y (¥B)▼ Net Debt
CashInv. Sec.Debt
4.31US$27.5M3.75US$23.9M'22/32.38US$15.2M3.09US$19.7M'23/34.22US$26.9M2.93US$18.7M'24/33.57US$22.7M1.99US$12.7M'25/33.83US$24.4M4.02US$25.7M'26/3
Shareholders
Top 10 hold 37.5%
1
Masahiro MORIMOTO
16.29%
2
Focus Systems Corporation
9.28%
3
Shigetomo IKEGAMI
6.71%
4
Ueda Yagi Tanshi Co., Ltd.
1.32%
5
GAKKEN HOLDINGS CO.,LTD.
0.99%
6
Nomura Securities Co., Ltd.
0.80%
7
Mitsubishi UFJ Morgan Stanley Securities Co., Ltd.
0.65%
8
Rakuten Securities, Inc. (Joint Account)
0.61%
9
Takashi HOTTA
0.45%
10
Shusaku NOZAKI
0.36%
Management
9 officers
Masahiro MORIMOTO
Representative Director, President, CEO
Born Apr 1966 Mar 1989: Commissioned, Japan Maritime Self-Defense Force Apr 1995: Joined Applied Materials Japan, K.K. Aug 2003: Founded the Company; Representative Director, President (current) Dec 2007: Representative Director, President, UBIC North America, Inc. (now FRONTEO USA, Inc.) Aug 2010: Director, Payment Card Forensics K.K. (Note 6) Apr 2015: Representative Director, Chairman, UBIC North America, Inc. (now FRONTEO USA, Inc.) (current)
1966-04-06
Hiroyoshi TOYOSHIBA
Director
Apr 1999: Worked at Kyushu University Hospital Mar 2000: Doctor of Science (Mathematics) May 2000: Worked at the U.S. National Institute of Environmental Health Sciences Oct 2004: Worked at National Institute for Environmental Studies Jul 2006: Joined Takeda Pharmaceutical Company Limited Apr 2017: Science Fellow, Takeda Pharmaceutical Company Limited May 2017: Joined the Company Oct 2019: Chief Technology Officer (CTO), the Company Jan 2020: General Manager, R&D Department, Life Science AI Business Division Jun 2021: Executive Officer Oct 2021: Director, Neuro-Linguistic Science Institute Oct 2023: General Manager, Life Science AI Business Division (current) Jun 2024: Director (current) Jun 2025: Chief Science Officer (CSO) (current)
1971-10-03
Makoto FUNAHASHI
Director
Apr 1968: Joined National Police Agency Mar 1999: Technical Councillor, National Police Agency Mar 2001: Special Advisor, U.S.E. Inc. Apr 2003: Joined NTT DATA Creation Co., Ltd. (now NTT DATA Eye Corporation) Jun 2003: Director, NTT DATA Creation Co., Ltd. Jun 2007: Director and Executive Officer, NTT DATA Creation Co., Ltd. Jun 2008: Advisor, NTT DATA Creation Co., Ltd. Jun 2008: Outside Director, the Company (current) Jun 2011: Director, Security Engineering Research Institute Inc. (current) Oct 2013: Director, Japan Image Recognition Association (current) Aug 2015: Director, Medical IT Security Forum (now Medical ISAC)
1945-12-28
Hirooki KIRISAWA
Director
Apr 1991: Joined Fukui Jiochi Co., Ltd. Aug 1996: Joined Toda JoZo Tax Accountant Office Apr 2000: Joined Animo Co., Ltd. Feb 2004: Founded Kirisawa Tax Accountant Office (now Hibiki Tax Corporation); Head of Office Aug 2005: Outside Audit & Supervisory Board Member, the Company Oct 2008: Representative Director, Management Farm Co., Ltd. (current) Jun 2010: Outside Director, the Company (current) Aug 2012: Representative Partner, Kirisawa Tax Corporation (now Hibiki Tax Corporation) (current)
1966-07-31
Taeko NAGAYAMA
Director
Apr 1973: Joined First Chicago Bank (now JPMorgan Chase Bank group) Apr 1983: Joined Manufacturers Hanover Bank group (now JPMorgan Chase Bank group) Jan 1994: Managing Director, Chemical Banking (now JPMorgan Chase Bank group) Nov 2001: Joined Credit Lyonnais Securities Co. (now Credit Agricole group) Dec 2005: Outside Director, Shady Co., Ltd. Apr 2007: Vice Chairman, Calyon Securities Co., Ltd. (now Credit Agricole group), Tokyo Branch Dec 2008: Representative Director, Preludors Co., Ltd. (current) Feb 2015: Advisor, the Company Mar 2021: Chair, Associate Member Liaison Committee, Foreign Correspondents' Club of Japan Jun 2021: Outside Director, the Company (current) Jun 2022: Director, Foreign Correspondents' Club of Japan (current)
1945-01-17
Masao TORII
Director
Apr 1971: Joined Nihon Roche K.K. (now Chugai Pharmaceutical Co., Ltd.) Apr 1989: Director, Nihon Roche K.K. Apr 1992: Managing Director, Nihon Roche K.K. Jan 1993: Representative Director, President, Rhone-Poulenc Rorer K.K. (now Sanofi K.K.) Jul 1995: Representative Director, President, Schering-Plough K.K. (now MSD K.K.) Jun 2010: Director, Nippon Boehringer Ingelheim Co., Ltd. Jan 2011: Representative Director, President, Boehringer Ingelheim Japan, Ltd.; Representative Director, Chairman of four wholly owned subsidiaries Sep 2011: Representative Director, President (concurrent), SS Pharmaceutical Co., Ltd. May 2013: Vice Chairman, EFPIA Japan Jul 2016: Representative Director, President, Novartis Holding Japan K.K. (now Novartis Pharma K.K.) Sep 2020: Director, Chairman, Novartis Pharma K.K. Sep 2021: Advisor, the Company Jun 2022: Outside Director, the Company (current) Jun 2022: Outside Director, Kohkando Co., Ltd. (current) Jul 2022: Non-Standing Audit & Supervisory Board Member, Acuris Pharma K.K.
1947-05-18
Kunihiro SUDO
Full-time Audit & Supervisory Board Member
Dec 1969: Joined Victor Company of Japan, Ltd. (now JVCKENWOOD Corporation) Jul 2002: Director, General Manager of Administration, Victor Leisure System Co., Ltd. Aug 2005: Retired from Victor Company of Japan, Ltd. (mandatory retirement) Oct 2005: Advisor, Victor Leisure System Co., Ltd. Mar 2007: Advisor, Exing Corporation Jul 2007: Joined Aquacast Co., Ltd. Oct 2007: Director, General Manager of Administration Division, Aquacast Co., Ltd. Apr 2011: Outside Audit & Supervisory Board Member, the Company (current)
1945-08-14
Takaharu YASUMOTO
Audit & Supervisory Board Member
Nov 1978: Joined Asahi Accounting Corporation (now Azusa Audit LLC) Aug 1982: Registered as Certified Public Accountant Apr 1992: Founded Yasumoto Certified Public Accountant Office; Principal (current) Nov 1993: Outside Audit & Supervisory Board Member, Fast Retailing Co., Ltd. Aug 2001: Outside Audit & Supervisory Board Member, ASKUL Corporation Jun 2003: Audit & Supervisory Board Member, Link International Inc. (now Link Theory Japan Co., Ltd.) Apr 2007: Specially Appointed Professor, Graduate School of International Accounting, Chuo University Jun 2010: Outside Audit & Supervisory Board Member, the Company (current) Mar 2020: Outside Audit & Supervisory Board Member, First Accounting Co., Ltd. (current)
1954-03-10
Kei OKUBO
Audit & Supervisory Board Member
Apr 2000: Registered as attorney-at-law; joined Nagashima Ohno & Tsunematsu Jan 2008: Partner, Nagashima Ohno & Tsunematsu (current) Jun 2016: Outside Audit & Supervisory Board Member, the Company (current)
1976-02-17
Large Shareholding Reports
Masahiro MORIMOTO
2026-03-23
10.25%→16.16%
Correction filing (name/detail fix only) — ratio carried over from the original filing
Annual report (as of 2026-03-31): 16.29%
Capstan Medical Co., Ltd.
2026-03-19
5.92%→0.00%
Masahiro MORIMOTO
2026-03-19
10.25%→16.16%
Annual report (as of 2026-03-31): 16.29%
Capstan Medical Co., Ltd.
2026-02-25
6.99%→5.92%
Masahiro MORIMOTO
2025-10-22
10.25%→10.25%
Annual report (as of 2026-03-31): 16.29%
Disclosures
No disclosures
Primary Source Filings
TDnet
2026-08-14
Q1 Earnings Flash
FY ending Mar 2027
EDINET
2026-06-23
Annual Securities Report
Period: Apr 2025 – Mar 2026
EDINETAmended
2026-03-23
Change Report
EDINET
2026-03-19
Large Shareholding Report
EDINET
2026-03-19
Large Shareholding Report
EDINET
2026-02-25
Large Shareholding Report
TDnet
2026-02-16
Q3 Earnings Flash
FY ending Mar 2026
EDINET
2025-11-14
Semi-Annual Securities Report
Period: Apr 2025 – Mar 2026
EDINET
2025-10-22
Large Shareholding Report
TDnet
2025-08-14
Q1 Earnings Flash
FY ending Mar 2026
EDINET
2025-06-24
Annual Securities Report
Period: Apr 2024 – Mar 2025
TDnet
2025-02-14
Q3 Earnings Flash
FY ending Mar 2025
EDINET
2024-11-14
Semi-Annual Securities Report
Period: Apr 2024 – Mar 2025
EDINETAmended
2024-10-25
Amended Annual Securities Report
Period: Apr 2022 – Mar 2023
EDINETAmended
2024-10-25
Amended Annual Securities Report
Period: Apr 2023 – Mar 2024
TDnet
2024-08-14
Q1 Earnings Flash
FY ending Mar 2025
EDINET
2024-06-28
Annual Securities Report
Period: Apr 2023 – Mar 2024
EDINET
2024-02-14
Quarterly Securities Report
Period: Oct 2023 – Dec 2023
EDINET
2023-11-14
Quarterly Securities Report
Period: Jul 2023 – Sep 2023
EDINET
2023-08-14
Quarterly Securities Report
Period: Apr 2023 – Jun 2023
EDINET
2023-06-30
Annual Securities Report
Period: Apr 2022 – Mar 2023
EDINET
2023-02-14
Quarterly Securities Report
Period: Oct 2022 – Dec 2022
EDINET
2022-11-14
Quarterly Securities Report
EDINET
2022-08-15
Quarterly Securities Report
EDINET
2022-06-30
Annual Securities Report
EDINET
2022-02-14
Quarterly Securities Report
EDINET
2021-11-15
Quarterly Securities Report
EDINET
2021-08-16
Quarterly Securities Report
EDINET
2021-06-30
Annual Securities Report
EDINETAmended
2021-02-17
Amended Quarterly Securities Report
Ask AI
I have this company's financials, ownership, and management on hand. Ask me anything from an M&A perspective.
End of Preview

Try the full product

Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.

Free Demo (No Time Limit, 10 Companies) →